Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$696M |
| 2 |
AABA
Altaba Inc
AABA
|
+$632M |
| 3 |
AT&T
T
|
+$433M |
| 4 |
Goldman Sachs
GS
|
+$392M |
| 5 |
Walt Disney
DIS
|
+$384M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.5B |
| 2 |
Apple
AAPL
|
+$1.26B |
| 3 |
Amazon
AMZN
|
+$1B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$938M |
| 5 |
Netflix
NFLX
|
+$423M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.9% |
| 2 | Financials | 1.28% |
| 3 | Communication Services | 1.02% |
| 4 | Consumer Discretionary | 0.99% |
| 5 | Healthcare | 0.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
CALL
Masco
MAS
$14.4B
| $14.4M | ﹤0.01% |
384,700
+24,900
| +7% | +$959K |
|
|
UN
1577
CALL
DELISTED
Unilever NV New York Registry Shares
UN
| $14.4M | ﹤0.01% |
257,900
-141,600
| -35% | -$7.92M |
|
1578
LKQ Corp
LKQ
$6.47B
| $14.4M | ﹤0.01% |
450,130
-17,629
| -4% | -$588K |
|
1579
Fair Isaac
FICO
$24.5B
| $14.4M | ﹤0.01% |
+74,249
| New | +$13.4M |
|
|
WPX
1580
PUT
DELISTED
WPX Energy, Inc.
WPX
| $14.3M | ﹤0.01% |
793,200
-334,400
| -30% | -$5.73M |
|
1581
PUT
Zimmer Biomet
ZBH
$19.4B
| $14.3M | ﹤0.01% |
132,046
+19,776
| +18% | +$2.15M |
|
1582
CALL
Perrigo
PRGO
$2.02B
| $14.3M | ﹤0.01% |
195,900
-49,600
| -20% | -$3.82M |
|
1583
PUT
Idexx Laboratories
IDXX
$43.6B
| $14.3M | ﹤0.01% |
65,400
+9,600
| +17% | +$1.98M |
|
|
CDK
1584
CALL
DELISTED
CDK Global, Inc.
CDK
| $14.2M | ﹤0.01% |
219,000
+117,000
| +115% | +$7.57M |
|
|
HTZ
1585
CALL
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $14.2M | ﹤0.01% |
1,065,020
+68,369
| +7% | +$1.11M |
|
|
CTLT
1586
DELISTED
CATALENT, INC.
CTLT
| $14.2M | ﹤0.01% |
+338,332
| New | +$13.7M |
|
1587
CALL
ProShares UltraPro S&P 500
UPRO
$5.5B
| $14.2M | ﹤0.01% |
604,600
+73,000
| +14% | +$1.69M |
|
1588
CALL
Moody's
MCO
$89B
| $14.1M | ﹤0.01% |
82,900
+38,600
| +87% | +$6.53M |
|
1589
PUT
Teladoc Health
TDOC
$1.16B
| $14.1M | ﹤0.01% |
243,400
+59,900
| +33% | +$2.93M |
|
|
MDCO
1590
CALL
DELISTED
Medicines Co
MDCO
| $14.1M | ﹤0.01% |
384,700
+86,800
| +29% | +$2.82M |
|
|
COL
1591
PUT
DELISTED
Rockwell Collins
COL
| $14.1M | ﹤0.01% |
104,700
+63,800
| +156% | +$8.63M |
|
1592
CALL
CRISPR Therapeutics
CRSP
$5.73B
| $14.1M | ﹤0.01% |
239,700
+139,000
| +138% | +$7.92M |
|
1593
Aflac
AFL
$58.7B
| $14.1M | ﹤0.01% |
327,212
+241,779
| +283% | +$10.9M |
|
1594
PUT
3D Systems Corp
DDD
$540M
| $14.1M | ﹤0.01% |
1,017,700
+48,800
| +5% | +$605K |
|
1595
CALL
BioMarin Pharmaceuticals
BMRN
$12.8B
| $14M | ﹤0.01% |
148,800
-97,100
| -39% | -$8.5M |
|
|
RUSL
1596
CALL
DELISTED
Direxion Daily Russia Bull 2X Shares
RUSL
| $14M | ﹤0.01% |
329,600
+5,800
| +2% | +$251K |
|
|
ELLI
1597
CALL
DELISTED
Ellie Mae Inc
ELLI
| $14M | ﹤0.01% |
134,700
+115,200
| +591% | +$11.7M |
|
1598
iShares Russell 1000 ETF
IWB
$48.9B
| $13.9M | ﹤0.01% |
91,498
+69,815
| +322% | +$10.5M |
|
1599
CALL
Dominion Energy
D
$58.9B
| $13.9M | ﹤0.01% |
203,900
-11,700
| -5% | -$762K |
|
1600
PUT
Direxion Daily Junior Gold Miners Index Bull 2X ETF
JNUG
$676M
| $13.9M | ﹤0.01% |
20,360
-3,120
| -13% | -$2.23M |
|
Similar funds
Jeff Yass's Q2 2018 Portfolio in Review
As of Q2 2018, Jeff Yass held 11,136 positions worth $291B, up 3.8% from $281B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass's Q2 2018 filing shows 1,911 new, 3,840 increased, 3,666 reduced and 1,619 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 4,732,803 shares worth $300M. The largest sale was Meta Platforms (Facebook), an estimated $1.5B.
By sector, the portfolio is most concentrated in Technology at 1.9% of assets, up from 1.8% a quarter earlier, followed by Financials and Communication Services.
- Jeff Yass's largest Q2 2018 buy was iShares Core MSCI EAFE ETF: 4,732,803 shares worth $300M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q2 2018, an estimated $696M increase.
- Jeff Yass's biggest Q2 2018 reduction was Meta Platforms (Facebook), cutting an estimated $1.5B.
- Jeff Yass fully exited iShares 0-1 Year Treasury Bond ETF in Q2 2018, selling an estimated $341M.
- Jeff Yass's ten largest holdings make up 26% of its $291B portfolio in Q2 2018.
- Jeff Yass opened 1,911 new positions and closed 1,619 in Q2 2018.
- Jeff Yass's portfolio value rose 3.8% quarter-over-quarter to $291B.
Based on Susquehanna International Group's 13F filing for Q2 2018, filed 14 Aug 2018.